INCREASED LEVELS OF SERUM PARATHYROID HORMONE AND FIBROBLAST GROWTH FACTOR-23 ARE THE MAIN FACTORS ASSOCIATED WITH THE PROGRESSION OF VASCULAR CALCIFICATION IN LONG-HOUR HEMODIALYSIS PATIENTS

被引：0
|
作者：
Jean, Guillaume [1 ]
Bresson, Eric [2 ]
Chazot, Charles [3 ]
机构：
[1] Nephrocare Tassin Charcot France, Sainte Foy Les Lyon, France
[2] Clin Protestante Caluire France, Lyon Caluire, France
[3] Nephrocate Tassin Charcot France, Sainte Foy Les Lyon, France
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2012年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
引用
收藏
页码：496 / 496
页数：1
相关论文
共 50 条
  • [41] Lower serum fibroblast growth factor-23 levels may suggest malnutrition in maintenance haemodialysis patients
    Mizuiri, Sonoo
    Nishizawa, Yoshiko
    Yamashita, Kazuomi
    Ono, Kyoka
    Oda, Maya
    Usui, Kohji
    Shigemoto, Kenichiro
    NEPHROLOGY, 2014, 19 (09) : 568 - 573
  • [42] High fibroblast growth factor 23 levels are associated with decreased ferritin levels and increased intravenous iron doses in hemodialysis patients
    Honda, Hirokazu
    Michihata, Tetsuo
    Shishido, Kanji
    Takahashi, Keiko
    Takahashi, Go
    Hosaka, Nozomu
    Ikeda, Misa
    Sanada, Daisuke
    Shibata, Takanori
    PLOS ONE, 2017, 12 (05):
  • [43] CALCITRIOL SUPPLEMENTATION INCREASES VON WILLEBRAND FACTOR LEVELS, FIBROBLAST GROWTH FACTOR-23 LEVELS, AND VASCULAR CALCIFICATION SEVERITY IN EXPERIMENTAL CHRONIC KIDNEY DISEASE
    Pruss, Cynthia M.
    Svajger, Bruno
    Zelt, Jason G. E.
    Laverty, Kimberly
    Ward, Emilie C.
    Holden, Rachel M.
    Adams, Michael A.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2016, 31 : 13 - 13
  • [44] Serum Intact Fibroblast Growth Factor 23 Levels Are Negatively Associated with Bone Mineral Density in Chronic Hemodialysis Patients
    Lee, Wen-Teng
    Fang, Yu-Wei
    Chen, Mingchih
    Liou, Hung-Hsiang
    Lee, Chung-Jen
    Tsai, Ming-Hsien
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (04)
  • [45] Serum vitamin D receptor and fibroblast growth factor-23 levels in postmenopausal primary knee osteoarthritis patients
    Tekeli, Feyza Yagmur
    Tekeli, Seckin Ozgur
    Kose, Ozkan
    TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI, 2022, 47 (06): : 788 - 794
  • [46] Plasma levels of fibroblast growth factor-23 and mineral metabolism in diabetic and non-diabetic patients on chronic hemodialysis
    Fumiko Kojima
    Keiko Uchida
    Tetsuya Ogawa
    Yoshiko Tanaka
    Kosaku Nitta
    International Urology and Nephrology, 2008, 40 : 1067 - 1074
  • [47] Plasma levels of fibroblast growth factor-23 and mineral metabolism in diabetic and non-diabetic patients on chronic hemodialysis
    Kojima, Fumiko
    Uchida, Keiko
    Ogawa, Tetsuya
    Tanaka, Yoshiko
    Nitta, Kosaku
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2008, 40 (04) : 1067 - 1074
  • [48] FIBROBLAST GROWTH FACTOR-23 AND PARATHYROID HORMONE PREDICT THE EXTENT OF AORTIC VALVE CALCIFICATIONS IN PATIENTS WITH CHRONIC KIDNEY DISEASE NOT ON DIALYSIS
    Di Lullo, Luca
    Russo, Domenico
    Gorini, Antonio
    Ronco, Claudo
    Santoboni, Alberto
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30
  • [49] Erythropoiesis stimulating agents are associated with serum fibroblast growth factor 23 metabolism in patients on hemodialysis
    Honda, Hirokazu
    Tanaka, Kenji
    Michihata, Tetsuo
    Shibagaki, Keigo
    Yuza, Toshitaka
    Hirao, Keiichi
    Tomosugi, Naohisa
    Ganz, Tomas
    Higashimoto, Yuichiro
    CLINICAL KIDNEY JOURNAL, 2021, 14 (03) : 943 - 949
  • [50] Fibroblast Growth Factor 23, but not Parathyroid Hormone, Is Associated With Urinary Phosphate Regulation in Patients on Peritoneal Dialysis
    Yamada, Shunsuke
    Tsuruya, Kazuhiko
    Tokumoto, Masanori
    Yoshida, Hisako
    Hasegawa, Shoko
    Tanaka, Shigeru
    Eriguchi, Masahiro
    Nakano, Toshiaki
    Masutani, Kosuke
    Ooboshi, Hiroaki
    Kitazono, Takanari
    THERAPEUTIC APHERESIS AND DIALYSIS, 2015, 19 (01) : 73 - 80
12345